Literature DB >> 15316006

The sialic acid component of the beta1 subunit modulates voltage-gated sodium channel function.

Daniel Johnson1, Marty L Montpetit, Patrick J Stocker, Eric S Bennett.   

Abstract

Voltage-gated sodium channels (Nav) are responsible for initiation and propagation of nerve, skeletal muscle, and cardiac action potentials. Nav are composed of a pore-forming alpha subunit and often one to several modulating beta subunits. Previous work showed that terminal sialic acid residues attached to alpha subunits affect channel gating. Here we show that the fully sialylated beta1 subunit induces a uniform, hyperpolarizing shift in steady state and kinetic gating of the cardiac and two neuronal alpha subunit isoforms. Under conditions of reduced sialylation, the beta1-induced gating effect was eliminated. Consistent with this, mutation of beta1 N-glycosylation sites abolished all effects of beta1 on channel gating. Data also suggest an interaction between the cis effect of alpha sialic acids and the trans effect of beta1 sialic acids on channel gating. Thus, beta1 sialic acids had no effect gating on the of the heavily glycosylated skeletal muscle alpha subunit. However, when glycosylation of the skeletal muscle alpha subunit was reduced through chimeragenesis such that alpha sialic acids did not impact gating, beta1 sialic acids caused a significant hyperpolarizing shift in channel gating. Together, the data indicate that beta1 N-linked sialic acids can modulate Nav gating through an apparent saturating electrostatic mechanism. A model is proposed in which a spectrum of differentially sialylated Nav can directly modulate channel gating, thereby impacting cardiac, skeletal muscle, and neuronal excitability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15316006     DOI: 10.1074/jbc.M408900200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Glycosylation of solute carriers: mechanisms and functional consequences.

Authors:  Nis Borbye Pedersen; Michael C Carlsson; Stine Falsig Pedersen
Journal:  Pflugers Arch       Date:  2015-09-18       Impact factor: 3.657

2.  N-glycosylation in regulation of the nervous system.

Authors:  Hilary Scott; Vladislav M Panin
Journal:  Adv Neurobiol       Date:  2014

Review 3.  Sodium channel β subunits: emerging targets in channelopathies.

Authors:  Heather A O'Malley; Lori L Isom
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

4.  Beta1-subunit modulates the Nav1.4 sodium channel by changing the surface charge.

Authors:  Loretta Ferrera; Oscar Moran
Journal:  Exp Brain Res       Date:  2006-01-24       Impact factor: 1.972

5.  The intracellular domain of the beta 2 subunit modulates the gating of cardiac Na v 1.5 channels.

Authors:  Thomas Zimmer; Klaus Benndorf
Journal:  Biophys J       Date:  2007-03-16       Impact factor: 4.033

6.  Reduced sialylation impacts ventricular repolarization by modulating specific K+ channel isoforms distinctly.

Authors:  Andrew R Ednie; Eric S Bennett
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

7.  Sialic acids attached to N- and O-glycans within the Nav1.4 D1S5-S6 linker contribute to channel gating.

Authors:  Andrew R Ednie; Jean M Harper; Eric S Bennett
Journal:  Biochim Biophys Acta       Date:  2014-10-30

8.  Possible role of sialylation of retinal protein glycans in the regulation of electroretinogram response in mice.

Authors:  Satpal Ahuja
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

9.  Asparagine-linked glycosylation modifies voltage-dependent gating properties of CaV3.1-T-type Ca2+ channel.

Authors:  Yangong Liu; Pu Wang; Fangfang Ma; Mingqi Zheng; Gang Liu; Shinichiro Kume; Tatsuki Kurokawa; Katsushige Ono
Journal:  J Physiol Sci       Date:  2019-01-01       Impact factor: 2.781

10.  Hereditary Inclusion Body Myopathy (HIBM2).

Authors:  Chris M Jay; Nick Levonyak; Gregory Nemunaitis; Phillip B Maples; John Nemunaitis
Journal:  Gene Regul Syst Bio       Date:  2009-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.